Article Details
Retrieved on: 2025-02-26 16:54:21
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details a clinical trial where an mRNA vaccine, Autogene cevumeran, was used on pancreatic cancer patients to stimulate immune response and extend survival. While relating to pancreatic issues, diabetes emerged post-surgery. Tags align by focusing on breakthrough cancer vaccine therapy, including key players like Dr. Vinod Balachandran.
Article found on: www.medicalbrief.co.za
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here